You have 9 free searches left this month | for more free features.

Respiratory Syncytial Virus Infections

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Respiratory Syncytial Virus Disease in Infants and Toddlers

Not yet recruiting
  • Respiratory Syncytial Virus Infections
    • (no location specified)
    Jul 27, 2023

    Respiratory Syncytial Virus Infections Trial in Saint Petersburg (RSV/Flu-01E low dose, RSV/Flu-01E high dose, Placebo)

    Active, not recruiting
    • Respiratory Syncytial Virus Infections
    • RSV/Flu-01E low dose
    • +2 more
    • Saint Petersburg, Russian Federation
      Smorodintsev Research Institute of Influenza
    Jul 24, 2023

    Respiratory Syncytial Virus Infections Trial (Placebo, Active)

    Not yet recruiting
    • Respiratory Syncytial Virus Infections
    • (no location specified)
    Oct 20, 2023

    Respiratory Syncytial Virus Infection Trial (Sisunatovir, Placebo)

    Not yet recruiting
    • Respiratory Syncytial Virus Infection
    • (no location specified)
    Oct 6, 2023

    Respiratory Syncytial Virus Infections Trial in Adelaide (Recombinant Respiratory Syncytial Virus Vaccine (BARS13) /,

    Active, not recruiting
    • Respiratory Syncytial Virus Infections
    • Recombinant Respiratory Syncytial Virus Vaccine (BARS13) /placebo
    • +2 more
    • Herston, Queensland, Australia
    • +1 more
    Feb 1, 2023

    RESCEU: Defining the Burden of RSV Disease

    Active, not recruiting
    • Respiratory Syncytial Virus Infections
    • RSV Infection
    • venepuncture
    • nasopharyngeal swab
    • Oxford, Oxfordshire, United Kingdom
      University of Oxford
    Oct 25, 2022

    Health and Economic Burden of RSV Amongst Hospitalized Children

    Recruiting
    • Respiratory Syncytial Virus Infections
      • Amman, Jordan
        Jordan University Hospital
      Dec 13, 2022

      Respiratory Syncytial Virus Infections Trial in London (RV299, Placebo, Midazolam)

      Completed
      • Respiratory Syncytial Virus Infections
      • London, Greater London, United Kingdom
        Richmond Pharmacology Ltd
      Sep 11, 2023

      Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, PCV20)

      Not yet recruiting
      • Respiratory Syncytial Virus Infections
      • RSVPreF3 OA investigational vaccine
      • PCV20
      • (no location specified)
      May 18, 2023

      Respiratory Syncytial Virus Infections Trial in Cincinnati (PIV5-vectored RSV Vaccine (BLB-201) Low Dose, PIV5-vectored RSV

      Not yet recruiting
      • Respiratory Syncytial Virus Infections
      • PIV5-vectored RSV Vaccine (BLB-201) Low Dose
      • +2 more
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center
      Dec 20, 2022

      Respiratory Syncytial Virus Infections Trial in Baltimore (200 mg RV521/78 µCi [ 14C]-RV521.)

      Completed
      • Respiratory Syncytial Virus Infections
      • 200 mg RV521/78 µCi [ 14C]-RV521.
      • Baltimore, Maryland
        Pharmaron Clinical Pharmacology Center
      May 15, 2023

      Respiratory Syncytial Virus Infections Trial (CodaVax-RSV, Normal Saline)

      Not yet recruiting
      • Respiratory Syncytial Virus Infections
      • CodaVax-RSV
      • Normal Saline
      • (no location specified)
      Nov 16, 2022

      Respiratory Syncytial Virus Infections Trial (Nirsevimab)

      Not yet recruiting
      • Respiratory Syncytial Virus Infections
      • (no location specified)
      Jun 24, 2022

      Respiratory Syncytial Virus Infections Trial in United States (AZM Group, Control Group)

      Recruiting
      • Respiratory Syncytial Virus Infections
      • AZM Group
      • Control Group
      • Birmingham, Alabama
      • +4 more
      Jun 16, 2022

      Respiratory Syncytial Virus Infections Trial in Baltimore, Laurel (RSV ?NS2 ?1313 I1314L Vaccine, Placebo)

      Recruiting
      • Respiratory Syncytial Virus Infections
      • RSV ΔNS2 Δ1313 I1314L Vaccine
      • Placebo
      • Baltimore, Maryland
      • +1 more
      Dec 2, 2022

      Respiratory Syncytial Virus Infection, Healthy Volunteers, Human Metapneumovirus Trial in Rolling Hills Estates, Miami,

      Recruiting
      • Respiratory Syncytial Virus Infection
      • +2 more
      • RSV/hMPV vaccine candidate Dose L
      • +3 more
      • Rolling Hills Estates, California
      • +2 more
      Nov 14, 2023

      Respiratory Syncytial Virus Infections Trial in Cincinnati, North Charleston (CPI-RSV-F Vaccine (BLB-201))

      Completed
      • Respiratory Syncytial Virus Infections
      • CPI-RSV-F Vaccine (BLB-201)
      • Cincinnati, Ohio
      • +1 more
      Dec 5, 2022

      Respiratory Syncytial Virus Infection Trial in Shanghai (Sisunatovir)

      Not yet recruiting
      • Respiratory Syncytial Virus Infection
      • Shanghai, Shanghai, China
        Huashan Hospital
      Aug 4, 2023

      Respiratory Syncytial Virus Infections Trial in Hakata, Sumida, Kumamoto (VN-0200)

      Recruiting
      • Respiratory Syncytial Virus Infections
      • VN-0200
      • Hakata, Fukuoka, Japan
      • +2 more
      Oct 27, 2022

      Respiratory Syncytial Virus Infections Trial in Changsha (XW001, Placebo)

      Completed
      • Respiratory Syncytial Virus Infections
      • Changsha, Hunan, China
        The Third Hospital of Changsha
      Nov 30, 2022

      COVID-19 Respiratory Infection, Influenza A, Influenza Type B Trial in Pasadena (Labcorp COVID-19+Flu+RSV Test Home Collection

      Recruiting
      • COVID-19 Respiratory Infection
      • +3 more
      • Labcorp COVID-19+Flu+RSV Test Home Collection Kit
      • Pasadena, California
        Exer Urgent Care
      Aug 21, 2023

      Respiratory Syncytial Virus Infections Trial in Baltimore (rRSV A/Maryland/001/11)

      Suspended
      • Respiratory Syncytial Virus Infections
      • rRSV A/Maryland/001/11
      • Baltimore, Maryland
        Johns Hopkins Bloomberg School of Public Health
      Feb 8, 2022

      Infant RSV Infections and Health-related Quality of Life of

      Recruiting
      • RSV Infection
      • +4 more
      • cohort study
      • Munich, Bavaria, Germany
        EFCNI
      Oct 14, 2022

      RSV Infection Trial in Chengdu (XW001, Placebo)

      Recruiting
      • RSV Infection
      • Chengdu, Sichuan, China
        West China Second University Hospital, Sichuan University
      Mar 20, 2023

      Respiratory Syncytial Virus Infections, Influenza, Human Trial in London (RSV A Memphis 37, Influenza A/California/04/2009)

      Terminated
      • Respiratory Syncytial Virus Infections
      • Influenza, Human
      • RSV A Memphis 37
      • Influenza A/California/04/2009
      • London, United Kingdom
        National Heart and Lung Institute, Imperial College London
      Jun 23, 2022